Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.79 |
| ▸ | PPARG | P37231 | 7/20 | 0.79 |
| ▸ | PPARD | Q03181 | 7/20 | 0.79 |
| ▸ | PPARA | Q07869 | 7/20 | 0.79 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.79 |
| ▸ | TSHR | P16473 | 4/20 | 0.79 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.79 |
| ▸ | FABP4 | P15090 | 3/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.79 |
| ▸ | TLR2 | O60603 | 2/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.79 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.79 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.79 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.79 |
| ▸ | MEN1 | O00255 | 1/20 | 0.79 |
| ▸ | ESR1 | P03372 | 1/20 | 0.79 |
| ▸ | PDE4A | P27815 | 1/20 | 0.79 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nonane SCHEMBL28234147 | 1.00 | GPR84 (0.79) | GPR84PPARGPPARDPPARAHDAC11 | |
| Tetradecane SCHEMBL27616455 | 1.00 | GPR84 (0.79) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octane SCHEMBL7563355 | 1.00 | GPR84 (0.79) | GPR84PPARGPPARDPPARAHDAC11 | |
| Heptane SCHEMBL7403977 | 1.00 | GPR84 (0.79) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decane SCHEMBL8483044 | 1.00 | GPR84 (0.79) | GPR84PPARGPPARDPPARAHDAC11 | |
| Hexadecane SCHEMBL27980697 | 1.00 | GPR84 (0.79) | GPR84PPARGPPARDPPARAHDAC11 | |
| Heptane SCHEMBL8097495 | 0.97 | GPR84 (0.75) | GPR84PPARGPPARDPPARAHDAC11 | |
| Butyric Acid SCHEMBL23014527 | 0.97 | FFAR3 (0.81) | GPR84PPARGPPARDPPARAHDAC11 | |
| Butyric Acid SCHEMBL59956 | 0.97 | FFAR3 (0.81) | GPR84PPARGPPARDPPARAHDAC11 | |
| Butyric Acid SCHEMBL7471228 | 0.97 | FFAR3 (0.81) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 475 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117956984-A | Novel microparticles containing active substances | 巴斯夫欧洲公司 | 2024-04-30 | — | — | CN | disclosed |
| US-20240109912-A1 | TRICYCLIC PYRIMIDINES AS CYCLIN-DEPENDENT KINASE 7 (CDK7) INHIBITORS | JANSSEN PHARMACEUTICA NV (BY) | 2024-04-04 | — | — | US | disclosed |
| US-11845758-B2 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms | PRINTNET KERESKEDELMI ÉS SZOLGÁLTATÓ KFT. (HU) | 2023-12-19 | — | — | US | disclosed |
| EP-4276102-A2 | PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS | Printnet Kereskedelmi és Szolgáltató Kft. (HU) | 2023-11-15 | — | — | EP | disclosed |
| US-20230339959-A1 | PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS | EÖTVÖS LORÁND TUDOMÁNYEGYETEM (HU) | 2023-10-26 | — | — | US | disclosed |
| EP-3807266-B1 | PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2023-10-25 | — | — | EP | disclosed |
| US-11746112-B2 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms | EÖTVÖS LORÁND TUDOMÁNYEGYETEM (HU) | 2023-09-05 | — | — | US | disclosed |
| EP-3781263-B1 | PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS | PRINTNET KERESKEDELMI ES SZOLGALTATO KFT (HU) | 2023-07-12 | — | — | EP | disclosed |
| US-20230203044-A1 | PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME | JANSSEN PHARMACEUTICA NV (BE) | 2023-06-29 | — | — | US | disclosed |
| US-11673880-B2 | Solid state forms of ivosidenib | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2023-06-13 | — | — | US | disclosed |
| US-4154943-A | Preparation of vincadifformine | UNIVERSITY OF VERMONT (US) | 1979-05-15 | — | — | US | disclosed |
| US-4049701-A | ANALGESICS, ANTIINFLAMMATORY | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-09-20 | — | — | US | disclosed |
| US-4001326-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
| US-4001331-A | ANTIINFLAMMATORY, ANALGESIC | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
| US-3979434-A | ANALGESICS, ANTIINFLAMMATORY | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-09-07 | — | — | US | disclosed |
| US-3976696-A | ANALGESIC, ANTIINFLAMMATORY | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-08-24 | — | — | US | disclosed |
| US-3976693-A | ANALGESIC, ANTIINFLAMMATORY | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-08-24 | — | — | US | disclosed |
| US-3957872-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-05-18 | — | — | US | disclosed |
| US-3937736-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-02-10 | — | — | US | disclosed |
| US-3931328-A | CARBURETOR | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203044-A1 | PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME | NLRP3, PYCARD, NLRP1 | GPR84 873/4885PPARG 1141/4885PPARD 561/4885 |
| US-11845758-B2 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms | MYH2, MYLK2, MYO1B | GPR84 4023/4885PPARG 3829/4885PPARD 4039/4885 |
| US-20240109912-A1 | TRICYCLIC PYRIMIDINES AS CYCLIN-DEPENDENT KINASE 7 (CDK7) INHIBITORS | CDK7, CDK2, CCNK | GPR84 3414/4885PPARG 1071/4885PPARD 1390/4885 |
| US-11673880-B2 | Solid state forms of ivosidenib | IDH1, IDH3B, FLT3 | GPR84 4726/4885PPARG 4754/4885PPARD 4520/4885 |
| US-11746112-B2 | Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms | MYH2, MYLK2, MYO1B | GPR84 4023/4885PPARG 3829/4885PPARD 4039/4885 |
| US-20230339959-A1 | PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS | MYH2, MYLK2, MYO1B | GPR84 4023/4885PPARG 3829/4885PPARD 4039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.